Dr. Reddy’s Laboratories (NYSE: RDY) clears dividend, auditor and director moves at AGM

Rhea-AI Filing Summary

Dr. Reddy’s Laboratories Limited held its 42nd Annual General Meeting on July 23, 2026 at 11:00 A.M. IST via Video Conferencing / Other Audio Visual Means in line with MCA and SEBI guidance. A quorum of 86 members holding 22,25,59,764 shares attended.

Shareholders approved adoption of the audited standalone and consolidated financial statements for the year ended March 31, 2026 and declared a final dividend of Rs. 8 per equity share of face value Re. 1 each. They re-appointed Mr. K Satish Reddy as director and appointed M/s. Deloitte Haskins & Sells LLP as statutory auditors for five consecutive years.

Special business included re-appointment of Dr. K P Krishnan as independent director for a second five-year term, appointment of Mr. Srikanth Velamakanni as independent director, and ratification of remuneration to cost auditors M/s Sagar & Associates for FY ending March 31, 2027. All resolutions were passed by requisite majority based on remote e-voting and e-voting during the AGM.

Key Figures

Final dividend: Rs. 8 per equity share Face value per share: Re. 1 per equity share Shares represented at AGM: 22,25,59,764 shares +5 more

8 metrics

Final dividend Rs. 8 per equity share Final dividend for the financial year ended March 31, 2026 on shares of face value Re. 1

Face value per share Re. 1 per equity share Face value of each equity share on which Rs. 8 dividend was declared

Shares represented at AGM 22,25,59,764 shares Held by 86 members attending the 42nd AGM via VC/OAVM

Members attending AGM 86 members Quorum present for the 42nd AGM held July 23, 2026

AGM timing 11:00 A.M. to 12:52 P.M. IST Duration of the 42nd AGM, including 30 minutes allowed for e-voting

Statutory auditor term Five (5) consecutive years Appointment of M/s. Deloitte Haskins & Sells LLP as statutory auditors

Independent director term Five (5) consecutive years Second term for independent director Dr. K P Krishnan approved at AGM

Cost auditor period Financial year ending March 31, 2027 Ratification of remuneration payable to cost auditors M/s Sagar & Associates

Key Terms

remote e-voting, Video Conferencing (VC) /Other Audio Visual Means (OAVM), Scrutinizer’s Report, requisite majority, +1 more

5 terms

remote e-voting regulatory

"facility to cast their votes electronically, on all resolutions set forth"

Video Conferencing (VC) /Other Audio Visual Means (OAVM) regulatory

"held on Thursday, July 23, 2026 at 11.00 AM (IST) through Video"

Scrutinizer’s Report regulatory

"The Scrutinizer’s Report was received, and accordingly all the resolutions"

requisite majority regulatory

"all the resolutions as set out in the Notice of the 42nd AGM were declared as passed by requisite majority"

Integrated Annual Report financial

"Integrated Annual Report for FY2025-26 containing the Audited Financial Statements"

An integrated annual report combines a company's formal financial statements with its narrative on strategy, governance, risks, and environmental, social and governance (ESG) performance into a single document. For investors it acts like a stitched-together map and guidebook — the numbers plus the context — making it easier to judge whether earnings are sustainable, management is credible, and long-term risks or opportunities are being managed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 6-K: How Foreign Companies Report to the SEC →

Available on EDGAR 07/23/2026 - 02:32 PM Accepted by SEC EDGAR 07/23/2026 - 02:31 PM Learn about SEC filing dates

FAQ

What was decided at Dr. Reddy’s (RDY) 42nd Annual General Meeting?

The 42nd AGM approved all resolutions, including adoption of FY2025-26 audited financial statements, a final dividend of Rs. 8 per share, key director appointments, and a new statutory auditor, M/s. Deloitte Haskins & Sells LLP, for five consecutive years.

What dividend did Dr. Reddy’s (RDY) shareholders approve for FY2025-26?

Shareholders approved a final dividend of Rs. 8 per equity share with a face value of Re. 1 each for the financial year ended March 31, 2026, as part of the ordinary business conducted at the 42nd AGM held via video conferencing.

Which auditor was appointed at Dr. Reddy’s (RDY) 42nd AGM and for how long?

Shareholders appointed M/s. Deloitte Haskins & Sells LLP as statutory auditors for a term of five consecutive years, with their remuneration to be fixed, replacing the prior firm as part of the ordinary business resolutions at the AGM.

What director changes were approved at Dr. Reddy’s (RDY) 42nd AGM?

The AGM approved the re-appointment of Mr. K Satish Reddy as director, the re-appointment of Dr. K P Krishnan as independent director for a second five-year term, and the appointment of Mr. Srikanth Velamakanni as an independent director.

How was voting conducted at Dr. Reddy’s (RDY) 42nd AGM and what was the outcome?

Voting was conducted through remote e-voting (July 19–22, 2026) and e-voting during the AGM via NSDL. Based on the Scrutinizer’s consolidated report, all resolutions in the AGM notice were declared passed by requisite majority.

What was the shareholder quorum at Dr. Reddy’s (RDY) 42nd AGM?

The AGM had a quorum of 86 members participating via VC/OAVM, collectively holding 22,25,59,764 equity shares. This satisfied the company’s Articles of Association requirements, allowing the chairman to call the meeting to order and conduct business.

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

July 2026

Commission File Number 1-15182

DR. REDDY’S LABORATORIES LIMITED

(Translation of registrant’s name into English)

8-2-337, Road No. 3, Banjara Hills

Hyderabad, Telangana 500 034, India

+91-40-49002900

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x                                  Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ______

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ______

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ¨                                  No x

If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.

EXHIBITS

Exhibit Number		Description of Exhibits
99.1		Intimation dated July 23, 2026

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	DR. REDDY’S LABORATORIES LIMITED (Registrant)
Date: July 23, 2026	By:	/s/ K Randhir Singh
		Name:	K Randhir Singh
		Title:	Company Secretary

3

Exhibit 99.1

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills Hyderabad – 500 034, Telangana, India CIN: L85195TG1984PLC004507 Tel:       + 91 40 4900 2900 Fax:     + 91 40 4900 2999 Email: mail@drreddys.com Web:   www.drreddys.com

July 23, 2026

National Stock Exchange of India Ltd. (Stock Code: DRREDDY)

BSE Limited (Stock Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY)

NSE IFSC Ltd. (Stock Code: DRREDDY)

Dear Sir/Madam,

Sub.: Outcome of 42nd Annual General Meeting and Voting results

This is with reference to our earlier letters dated May 12, 2026 and June 30, 2026, regarding the 42^nd Annual General Meeting (‘AGM’) of the Company, held today, i.e., July 23, 2026.

Pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), this is to inform you that the Members of the Company transacted the business as stated in the Notice of 42^nd AGM, dated May 12, 2026, through Video Conferencing (‘VC’)/Other Audio-Visual Means (‘OAVM’) facility.

In this regard, please find enclosed the following:

	1.	Pursuant to Regulation 30 of the SEBI Listing Regulations, a summary of the 42nd AGM proceedings - Annexure - A.
	2.	The consolidated Scrutinizer’s Report on the remote e-voting and e-voting during the AGM - Annexure - B.
	3.	The agenda-wise disclosure of voting details - Annexure - C.

The above mentioned documents are also being uploaded on the Company's website at www.drreddys.com and on the website of National Securities Depository Limited at www.evoting.nsdl.com.

Thanking you.

For Dr. Reddy’s Laboratories Limited

 

K Randhir Singh

Company Secretary, Compliance Officer and Head-CSR

Encl: As above

CC: National Securities Depositary Limited (NSDL)

   Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills Hyderabad – 500 034, Telangana, India CIN: L85195TG1984PLC004507 Tel:       + 91 40 4900 2900 Fax:     + 91 40 4900 2999 Email: mail@drreddys.com Web:   www.drreddys.com

Annexure-A

DR. REDDY’S LABORATORIES LIMITED

Summary of proceedings of the 42^nd Annual General Meeting (‘AGM’) of the Members of Dr. Reddy’s Laboratories Limited (‘the Company’) held on Thursday, July 23, 2026 at 11.00 AM (IST) through Video Conferencing (VC) /Other Audio Visual Means (OAVM). The Meeting was held in compliance with the General Circular issued by the Ministry of Corporate Affairs (‘MCA’) and circular issued by the Securities and Exchange Board of India (‘SEBI’) and as per the applicable provisions of the Companies Act, 2013 and the Rules made thereunder.

Directors Present through VC:

1.	Mr. K Satish Reddy	Chairman and Member, participated from Hyderabad, India
2.	Mr. G V Prasad	Co-Chairman and Managing Director and Member, participated from Hyderabad, India
3.	Mr. Leo Puri	Independent Director, Chairman of Stakeholders’ Relationship Committee, participated from Mumbai, India
4.	Ms. Shikha Sharma	Independent Director, Chairperson of Risk Management Committee, participated from Hyderabad, India
5.	Dr. K P Krishnan	Independent Director, Chairman of the Sustainability & Corporate Social Responsibility Committee, participated from Hyderabad, India
6.	Ms. Penny Wan	Independent Director, participated from Hyderabad, India
7.	Mr. Arun M Kumar	Independent Director, Chairman of the Audit Committee, participated from Mumbai, India
8.	Dr. Claudio Albrecht	Independent Director, Chairman of Science, Technology and Operations Committee, participated from Bangalore, India
9.	Dr. Alpna Seth	Independent Director, participated from New Delhi, India
10.	Mr. Sanjiv Mehta	Independent Director, Chairman of Nomination, Governance and Compensation Committee, participated from Mumbai, India
11.	Mr. Srikanth Velamakanni	Independent Director, participated from New Delhi, India

In attendance through VC, participated from Hyderabad, India:

1.	Mr. Erez Israeli	Chief Executive Officer
2.	Mr. M V Narasimham	Chief Financial Officer
3.	Mr. K Randhir Singh	Company Secretary, Compliance Officer and Head-CSR

Other representatives through VC:

1.	Representatives of M/s. S.R. Batliboi & Associates LLP, Statutory Auditors, participated from Hyderabad, India
2.	Mr. Atul Mehta, Scrutinizer, Founding Partner, M/s. Mehta & Mehta, Practicing Company Secretaries, participated from Mumbai, India
3.	Mr. Lakshmi Kant Sharma, Representatives of Makarand M. Joshi & Co., Company Secretaries, Secretarial Auditor, participated from Mumbai, India

Quorum of the Meeting: -

Total 86 members holding 22,25,59,764 shares, attended the meeting through VC/OAVM.

Pursuant to Article 70 of the Articles of Association of the Company, Mr. K Satish Reddy, the Chairman of the Board took the chair and conducted the proceedings of the meeting. The requisite quorum being present, the meeting was called to order. Chairman extended a warm welcome to all members and other participants.

Thereafter, the Company Secretary informed the members that the meeting is being held through Video Conferencing/ Other Audio Visual Means (OAVM) in compliance with the applicable Circulars issued by the Ministry of Corporate Affairs (‘MCA’) and Securities and Exchange Board of India (‘SEBI’). The Company Secretary further stated that since the Integrated Annual Report for FY2025-26 containing the Notice of the 42^nd AGM and the Auditor’s Report was circulated to the members through electronic mode, the Notice convening the meeting and the Auditor’s Report are taken as read. Thereafter, the Chairman delivered his speech followed with the address by the Co-Chairman and Managing Director.

The Members were informed that the Integrated Annual Report for FY2025-26 containing the Audited Financial Statements (both Standalone and Consolidated) for the year ended March 31, 2026, Board’s and Auditor’s report had been sent through electronic mode to all the members whose e-mail addresses were registered with the Company/ Depository Participant(s)/ Registrar and Transfer Agent. Also the letter containing weblink & Quick Response code (QR code) of Integrated Annual Report to those shareholders who have not registered their email addresses were sent through postal mode. The members were also informed that the original documents, as referred to in the Integrated Annual Report, along with the statutory registers were made available for inspection in electronic mode before and during the 42^nd AGM.

Thereafter, the moderator opened the Question & Answer session for the Speaker Shareholders to ask their queries.

Members attending the AGM, who had pre-registered themselves as speakers were given an opportunity to ask questions or comments. In addition to certain queries on financial statements, the members sought clarifications on key business, use of Artificial Intelligence in business operations and financial matters. These queries were adequately responded by the Management.

The members were further informed that the Company had provided the facility to cast their votes electronically, on all resolutions set forth in the Notice of the 42^nd AGM through remote e-voting provided by NSDL. The remote e-voting facility was open from Sunday, July 19, 2026 (9:00 A.M. IST) to Wednesday, July 22, 2026 (5:00 P.M. IST). Members who attended the AGM and had not cast their votes through remote e-voting prior to the meeting were provided an opportunity to cast their votes during the AGM through the e-voting facility provided by NSDL.

The following items of business, as per the Notice of the 42^nd AGM dated May 12, 2026 were transacted at the meeting:

S.No.	Resolutions	Type of Resolution
Ordinary Business
1	Adoption of the Audited Financial Statements (Standalone and Consolidated) of the Company for the financial year ended March 31, 2026, together with the Reports of the Board of Directors and Auditors thereon.	Ordinary
2	Declaration of final dividend of Rs. 8/- per equity share of the face value of Re. 1/- each, for the financial year ended March 31, 2026.	Ordinary
3	Re-appointment of Mr. K Satish Reddy (DIN: 00129701), as a Director, who retires by rotation and being eligible, has offered himself for re-appointment.	Ordinary
4	Appointment of M/s. Deloitte Haskins & Sells, LLP, Chartered Accountants as a Statutory Auditors for a period of five (5) consecutive years and fix their remuneration.	Ordinary

Special Business
5	Re-appointment of Dr. K P Krishnan (DIN: 01099097), as an Independent Director for a second term of five (5) consecutive years.	Special
6	Appointment of  Mr. Srikanth Velamakanni (DIN: 01722758), as an Independent Director of the Company.	Special
7	Ratification of remuneration payable to cost auditors, M/s Sagar & Associates, Cost Accountants, for the Financial Year ending March 31, 2027	Ordinary

The Chairman informed the members that Mr. Atul Mehta (Membership No. F5782 and COP No. 2486), Founding Partner, M/s Mehta & Mehta, Company Secretaries, was appointed as the Scrutinizer for scrutinizing the processes of remote e-voting prior to the meeting and e-voting during the AGM in a fair and transparent manner and to report on the voting results for the items as per the Notice of the 42nd AGM. The Chairman also informed the members that the Company Secretary is authorised on behalf of the board, to declare the voting results, intimate the stock exchanges, and place the same on the website of the Company.

The meeting commenced at 11:00 A.M. IST. and concluded at 12:52 P.M. IST (including 30 minutes time allowed for e-voting during AGM).

The Scrutinizer’s Report was received, and accordingly all the resolutions as set out in the Notice of the 42^nd AGM were declared as passed by requisite majority.

For Dr. Reddy’s Laboratories Limited

K Randhir Singh

Company Secretary, Compliance Officer and Head-CSR

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 EXHIBIT 99.1 68.7 KB